US Dollar vs Yen

ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

登録

ホーム
投資
株式
アメリカ
NASDAQ
Tevogen Bio Holdings Inc (TVGNW)
Tevogen Bio Holdings Inc (TVGNW) ニュース

TVGNW

Tevogen Bio (TVGNW)

Tevogen Bio Holdings Inc

から:

Regulatory News

Text Search:

次の項目別のソート:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:TVGNW

1

日付	受信時刻	ニュースソース	見出し	コード	企業名
2024/06/08	05 : 29	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/06/08	04 : 32	GlobeNewswire Inc.	CORRECTION – Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Public Listing Social Engagement Event	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/06/07	07 : 14	GlobeNewswire Inc.	Tevogen Bio Expresses Gratitude to Patients, First Responders, Elected Officials, and Members of the United States Congress for Attending Its Inaugural Post-Listing Social Engagement Event	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/06/07	04 : 52	GlobeNewswire Inc.	Tevogen Bio Confirms Ongoing Efficacy of TVGN 489, Its Investigational Allogeneic Off-the-Shelf Immunotherapy, Against Dominant FLiRT Strains of SARS-CoV-2	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/05/31	05 : 30	Edgar (US Regulatory)	Form 8-K/A - Current report: [Amend]	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/05/29	21 : 00	GlobeNewswire Inc.	Tevogen Bio Reports First Quarter 2024 Financial Results	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/05/29	06 : 22	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/05/17	06 : 01	Edgar (US Regulatory)	Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/05/17	05 : 52	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/05/17	03 : 00	GlobeNewswire Inc.	Tevogen Bio Appoints Former Police Chief & FBI National Academy Graduate, William Keane, as Vice President of Strategic Initiatives	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/05/11	06 : 40	GlobeNewswire Inc.	Tevogen Bio Announces Up to $50 Million in Financing to Further Advance Operational Objectives	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/05/01	21 : 05	GlobeNewswire Inc.	Tevogen Bio Announces Full Year 2023 Financial Results and Upcoming Operational Objectives	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/04/26	22 : 23	GlobeNewswire Inc.	Tevogen Bio CEO Highlights Expected Reporting of a $94.9 Million Liability Elimination, AI Initiative, and Leadership Appointments	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/04/11	21 : 05	GlobeNewswire Inc.	Tevogen Bio’s Chief Scientific Officer Speaks on the Harnessing of Cytotoxic T Lymphocytes (CTLs) to Target Cancers	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/04/03	21 : 05	GlobeNewswire Inc.	Tevogen Bio Appoints Tapan V Shah as Head of Investor Relations and Corporate Development	NASDAQ:TVGNW	Tevogen Bio Holdings Inc
2024/03/28	21 : 05	GlobeNewswire Inc.	Tevogen Bio Reports Series A-1 Preferred Stock Investment at $10 Conversion Price	NASDAQ:TVGNW	Tevogen Bio Holdings Inc

Showing the most relevant articles for your search:NASDAQ:TVGNW

1

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約